Biotech Stock Still 700%: What Investors Should Do Today
A biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
BTC has broader recognition and acceptance in stores and wallets, while ETH benefits from a thriving developer ecosystem. This look compares adoption levels.
27,775 articlesA biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Young graduates facing scarce first jobs as data show the entry-level market worst it’s unfolding despite a steadier ...
Import prices surged in February, signaling higher inflation coming import pressures. Markets waver as traders price ...
A Russian actor allegedly used forged ties to the Astor name to extract roughly $450 million from a Mexican billionai...
Rigetti's Q1 earnings tonight could shape the next move for its stock as Novera shipments and Cepheus milestones feed...
Iren has closed a $3 billion convertible notes sale at a 1% coupon, due 2033, to bankroll its AI cloud infrastructure...
A rising trend known as 'listing agent demands raise' is drawing scrutiny from regulators and industry groups as buye...
Chase Stokes has sold his South Carolina home for $3 million after completing the final season of Outer Banks, signal...
Investors are pricing rate hikes through 2027 as the Fed cuts outlook fades, reshaping bond yields and stock valuatio...
Two US-listed spot HYPE ETFs began trading this month and posted a powerful start, with nine straight days of inflows...
A 68-year-old retiree taps a charitable remainder trust strategy to divest a $2.4 million concentrated stock position...
Marvell Technology’s stock rises to a 25-year high, lifting its S&P 500 position to No. 22. Analysts point to AI-driv...